yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36207446-257661F4-C71A-4206-9E88-76F07D972374
Q36207446-257661F4-C71A-4206-9E88-76F07D972374
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36207446-257661F4-C71A-4206-9E88-76F07D972374
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma
P2860
Q36207446-257661F4-C71A-4206-9E88-76F07D972374
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36207446-257661F4-C71A-4206-9E88-76F07D972374
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aed41efda20f89415218ca789ba4a156b6f6d5f1
P2860
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.